Menopausal hormone therapy and pulmonary diseases

This paper examines the impact of menopausal hormone therapy (MHT) on various pulmonary diseases, addressing the question of how MHT influences respiratory health in menopausal women. The authors highlight mixed evidence regarding MHT's effects on asthma, chronic obstructive pulmonary disease, pulmonary hypertension, obstructive sleep apnea, and lung cancer, emphasizing the need for individualized treatment plans based on specific patient risks and disease characteristics.